Experience summary of Professor Yao Kuiwu in treating coronary heart disease from the relationship between pathogen and vital qi
HUA Xin1,2 CUI Yanjing2 ZHU Aisong3 XU Shuxin2 WANG Qingqing2 LIN Jian’guo2 YAO Kuiwu2
1.The First Clinical Medical College, Shaanxi University of Chinese Medicine, Shaanxi Province, Xianyang 712046, China;
2.Department of Cardiology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China;
3.Basic Medical College, Zhejiang Chinese Medical University, Zhejiang Province, Hangzhou 310053, China
Abstract：Professor Yao Kuiwu believes that the occurrence of coronary heart disease is based on the deficiency of qi, accompanied by the change of the relationship between pathogen and vital qi. The essence of the change of the relationship between pathogen and vital qi is the transformation of the deficiency and excess of human specimens, which is the manifestation of the disharmony of human harmony, specifically the disharmony of qi and blood, the disorder of ascending and descending, the imbalance of liver and spleen, and the loss of emotion. During the treatment, Professor Yao Kuiwu follows the “harmony” thought, takes the “harmony” method as the guide, adhere to the combination of syndrome differentiation and disease differentiation, and treats through the coordinating of qi and blood, promoting blood circulation, regulating liver and spleen, promoting clearing and reducing turbidity, and regulating emotions. The method can make the human body reach the state of harmony of qi and blood, unobstructed qi, and harmony of emotions, then the healthy qi will be filled, the pathogenic qi will go away, and the clinical treatment of coronary heart disease will be effective.
华鑫1，2 崔艳静2 朱爱松3 徐舒欣2 王擎擎2 林建国2 姚魁武2. 姚魁武教授从邪正关系论治冠心病经验总结[J]. 中国医药导报, 2021, 18(15): 149-152.
HUA Xin1,2 CUI Yanjing2 ZHU Aisong3 XU Shuxin2 WANG Qingqing2 LIN Jian’guo2 YAO Kuiwu2. Experience summary of Professor Yao Kuiwu in treating coronary heart disease from the relationship between pathogen and vital qi. 中国医药导报, 2021, 18(15): 149-152.
京公网安备 11010502046598号